Defects in the mitochondrion, the energy-producing unit of the cell, lead to a wide range neural and muscular diseases caused by decreased energy production, free radical damage, and perturbations to apoptotic pathways. The protein import pathways of the mitochondrion mediate the import and assembly of proteins from the cytosol. The X-linked disease Mohr-Tranebjaerg syndrome or deafness-dystonia syndrome is caused by a specific defect in the import of inner membrane proteins. The goal of this proposal is to investigate the mechanism of protein import into the mitochondrion in the experimental model, the budding yeast Saccharomyces cerevisiae and to extend our studies into mammalian systems. The TIM22 import pathway and the Erv1/Mia40 oxidative folding pathway will be targeted. The objective of this research is to define the molecule mechanisms of protein import with a combined biochemical, biophysical, and genetic approach. Specifically, the mechanism by Mia40 and Erv1 mediate protein import and disulfide bond assembly in the intermembrane space will be elucidated. In addition, a chemical- genetic approach will be utilized to identify small molecule effectors that may modulate the TIM 22 import pathway, with the long-term goal of developing therapeutics for deafness-dystonia syndrome and other mitochondrial disorders, as well as the Mia40/Erv1 pathway with a long- term goal of understanding the molecular basis of a new mitochondrial disease caused by mutations in Erv1. The proposed project will expand fundamental knowledge about the mechanism of protein insertion into the mitochondrial inner membrane, extending present studies that have focused generally on the mechanism by which proteins reach soluble compartments of the mitochondrion. Importantly, this research will generate new chemical probes for investigating mitochondrial assembly in yeast, cultured mammalian cells, and animal models such as fly, worms, and zebrafish that will be available to the mitochondrial research community. This research will impact public health because these mechanistic studies will provide insight into how defects in mitochondrial biogenesis lead to diseases such as deafness- dystonia syndrome, Friedreich's ataxia, and Parkinson's and Alzheimer's disease, which are caused by mitochondrial dysfunction. The ultimate goal of this research is to use our models in a chemical-genetic approach to identify small molecule effectors, which in the long-term may lay the groundwork for developing new tools to understand how mitochondrial defects lead to human diseases and new therapeutic approaches to develop drugs that will modulate mitochondrial function.

Public Health Relevance

This proposal is relevant to public health because it will provide fundamental knowledge of protein import and assembly pathways in mitochondria that will translate into a better understanding of the molecular basis of a subset of mitochondrial diseases. Also, this proposal will generate new tools for studying mitochondrial function in humans that will be valuable in the development of diagnostics and therapeutics for mitochondrial diseases, such as mitochondrial myopathy and neuropathy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM061721-13
Application #
8541025
Study Section
Membrane Biology and Protein Processing (MBPP)
Program Officer
Ainsztein, Alexandra M
Project Start
2000-09-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
13
Fiscal Year
2013
Total Cost
$364,493
Indirect Cost
$122,338
Name
University of California Los Angeles
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Miyata, Non; Steffen, Janos; Johnson, Meghan E et al. (2014) Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. Proc Natl Acad Sci U S A 111:14406-11
Yien, Yvette Y; Robledo, Raymond F; Schultz, Iman J et al. (2014) TMEM14C is required for erythroid mitochondrial heme metabolism. J Clin Invest 124:4294-304
Hildick-Smith, Gordon J; Cooney, Jeffrey D; Garone, Caterina et al. (2013) Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. Am J Hum Genet 93:906-14
Levesque, Mitchell P; Krauss, Jana; Koehler, Carla et al. (2013) New tools for the identification of developmentally regulated enhancer regions in embryonic and adult zebrafish. Zebrafish 10:21-9
Dabir, Deepa V; Hasson, Samuel A; Setoguchi, Kiyoko et al. (2013) A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev Cell 25:81-92
Wang, Geng; Shimada, Eriko; Zhang, Jin et al. (2012) Correcting human mitochondrial mutations with targeted RNA import. Proc Natl Acad Sci U S A 109:4840-5
Claypool, Steven M; Koehler, Carla M (2012) The complexity of cardiolipin in health and disease. Trends Biochem Sci 37:32-41
Zhang, Jin; Khvorostov, Ivan; Hong, Jason S et al. (2011) UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J 30:4860-73
Claypool, Steven M; Whited, Kevin; Srijumnong, Santi et al. (2011) Barth syndrome mutations that cause tafazzin complex lability. J Cell Biol 192:447-62
Wang, Geng; Chen, Hsiao-Wen; Oktay, Yavuz et al. (2010) PNPASE regulates RNA import into mitochondria. Cell 142:456-67

Showing the most recent 10 out of 32 publications